Teza Capital Management’s NEVRO CORP. NVRO Stock Holding History

Teza Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,096	Closed	-$354K	–	447
2018 Q4	$354K	Buy	9,096 +2,092	+30%	+$93K	0.13%	234
2018 Q3	$399K	Buy	7,004 +1,960	+39%	+$123K	0.09%	286
2018 Q2	$403K	Buy	+5,044	New	+$418K	0.06%	391
2017 Q2	–	Sell	-6,233	Closed	-$584K	–	391
2017 Q1	$584K	Buy	+6,233	New	+$565K	0.17%	204

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Teza Capital Management's NVRO Position: Q1 2019 in Review

Teza Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2019, closing a stake of 9,096 shares — an estimated $354K sold.

Teza Capital Management first reported a position in NVRO in Q1 2017 and held it in 4 quarters. The position peaked at $584K in Q1 2017. 172 funds tracked by Wall St. Rank hold NVRO as of Q1 2019.

Teza Capital Management reported no remaining NEVRO CORP. position as of Q1 2019 after selling out during the quarter.
Teza Capital Management sold 9,096 NEVRO CORP. shares in Q1 2019, an estimated $354K.
Teza Capital Management first reported a position in NEVRO CORP. in Q1 2017 and held it in 4 quarters.
Teza Capital Management's NEVRO CORP. position peaked at $584K in Q1 2017.
172 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2019.

Based on Teza Capital Management's 13F filing for Q1 2019, filed 13 May 2019.